The angiographic effect of ergonovine and nifedipine in coronary artery spasm.
- 1 November 1980
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 62 (5) , 1127-1130
- https://doi.org/10.1161/01.cir.62.5.1127
Abstract
In a patient with variant angina, we have shown that the calcium-channel blocker nifedipine inhibits both spontaneous and ergonivine-induced coronary artery spasm. It had no effect, however, on the dose-related diffuse vasoconstriction caused by ergonovine, suggesting two distinct responses of coronary arteries to ergonovine provocation. Nifedipine did not cause epicardial coronary artery dilatation, as did nitroglycerin, supporting the rationale of using both therapies together to treat coronary artery spasm.This publication has 8 references indexed in Scilit:
- Nifedipine in the treatment of prinzmetal's (variant) anginaThe American Journal of Cardiology, 1979
- Provocative testing with ergonovine to evaluate the efficacy of treatment with calcium antagonists in variant angina.Circulation, 1979
- The effects of ergonovine maleate on coronary arterial size.Circulation, 1979
- Ergonovine maleate provocative test for coronary arterial spasmThe American Journal of Cardiology, 1978
- Effects of ergonovine in patients with and without coronary artery disease.Circulation, 1977
- Provocation of coronary spasm with ergonovine maleateThe American Journal of Cardiology, 1977
- Provocative testing for coronary arterial spasm: Rationale, risk and clinical illustrationsThe American Journal of Cardiology, 1977
- Coronary arterial spasm in Prinzmetal's angina: A proved hypothesisThe American Journal of Cardiology, 1976